Wholesale prices posted an unexpected decline in February, providing some encouraging news on inflation as the Federal Reserve weighs its next move on interest rates.
The producer price index fell 0.1% for the month, against the Dow Jones estimate for a 0.3% increase and compared to a 0.3% gain in January. On a 12-month basis, the index increased 4.6%, well below the downwardly revised 5.7% level from the previous mon...

✅ Revenue +8% Y/Y to $23.5B
($0.2B beat).
✅ Non-GAAP EPS $0.99
($0.20 beat).
❌Media not profitable:
Can't imagine Disney produce so many good movies... but can't make a profit from them 😂
❌Jobs & Budget cuts:
- Firing 7,000 employees & slashing $5.5B in cost.
- Catch-22 here: they need to trim expenses. But at the same time, they can't grow if they are trimming.
❌ Dividends:
Reintroducing dividends when the business segments & cash flow are not stabilized yet seems puz...

• Rev +9% Y/Y to $149.2B ($3.4B beat).
• Operating margin 2% (-2pp Y/Y).
• Non-GAAP EPS $0.03 ($0.14 miss).
AWS:
• Revenue +20% Y/Y to $21.4B.
• Operating margin 24% (-6pp Y/Y).
Q1 FY23 Guidance:
• Revenue ~$123.5B ($2B miss).
Thoughts:
Growth slowdown:
The economy & recession is causing the business to slowdown, so revenue slowdown is expected. but i would like to see it pickling up again in 6-9 months' time.
(At such a large size, it's hard to keep growing at such a high pace to...

• Revenue -5% Y/Y to $117.2B ($4.5B miss).
💳 Services +6% Y/Y to $20.8B.
📱 Products -8% Y/Y to $96.4B.
• Operating margin 31% (-2pp Y/Y).
• Operating cash flow margin 29%.
• EPS $1.88 ($0.07 miss).
Segments growth in Q1 23:
- iPhone: -8% YoY
- Mac: -29% YoY
- Ipad: +30% YoY
- Wearables, Home & Accessories: -8% YoY
- Services: +6% YoY
Net sales: -5.5%
Summary:
✳️ Apple's fiscal Q1 revenue and EPS miss was the first in at least 20 quarters, if not longer.
✳️ However, the business's fu...

- Q4 Non-GAAP EPS of $1.14 beats by $0.10.
- Revenue of $24.3B (+1.9% Y/Y) misses by $100M.
2023 Guidance:
- Rev of $67.0 to $71.0 Billion vs. $74.23B consensus
- Adjusted Diluted EPS of $3.25 to $3.45 vs $4.38 consensus
Revenues from COVID-19 products expected to grow in 2024 after reaching a low point in 2023 due to significant government supply on hand to start the year.